**Health and Beauty Products:** approx. 40%
**Food:** approx. 35%
**Household Goods:** approx. 25%

**TOP 3 Markets:**
1. **Japan:** approx. 85%
2. **China:** approx. 10%
3. **South Korea:** approx. 5%

Genky DrugStores Co., Ltd. generates the majority of its revenue from the sale of health and beauty products, followed by food and household goods. The main market is Japan, where the company generates the largest portion of its income. China and South Korea are also important markets, but they contribute a significantly smaller share of the total revenue.

This distribution reflects the company's strong presence and focus on the domestic market while simultaneously seeking to expand its international reach.

**Production Sites:** No specific current data available (as of 2026)

Genky DrugStores Co., Ltd. primarily operates as a retail company in the field of drugstores and pharmacies. The company is known for selling health and beauty products as well as food items.

Typically, companies in this industry source their products from various manufacturers and suppliers rather than producing them themselves. Therefore, it is likely that Genky DrugStores sources its products from third-party suppliers, which may be located both domestically and internationally.

For detailed information on specific production sites or suppliers, a direct inquiry to the company or access to their financial reports would be necessary.

**Revenue Growth:** 8.5% (estimated for 2025)
**Expansion of Stores:** 50 new locations annually (planned for 2024-2026)

Genky DrugStores Co., Ltd. is pursuing a growth strategy that heavily focuses on expanding its network of stores. The company plans to open approximately 50 new locations each year to strengthen its market presence in Japan. This expansion will take place in both urban and rural areas to reach a broader customer base.

In addition, Genky is investing in digitalization and expanding its online business. This includes enhancing their e-commerce platform and integrating omnichannel solutions to provide customers with a seamless shopping experience.

Another focus is on diversifying the product offering, especially in the health and beauty products sector, to meet changing customer needs and tap into new sources of revenue.

**Important import materials:** Pharmaceutical raw materials, cosmetic ingredients, dietary supplements

**Main importing countries:** China, Germany, USA

Genky DrugStores Co., Ltd. imports a variety of raw materials necessary for the production and distribution of their products. These include pharmaceutical raw materials used in the manufacturing of medicines and health products. These are often imported from countries like China, which is a significant supplier of pharmaceutical raw materials.

In addition, the company sources cosmetic ingredients from countries like Germany, known for its high-quality cosmetic products. Dietary supplements and special ingredients could also be imported from the USA, a leading market for innovative health products.

These import strategies help Genky DrugStores to offer a wide range of products while ensuring the quality and diversity of their offerings.

**Market share in the industry:** 5.2% (2025, estimated)
**Revenue growth:** 8.1% (2025)
**Profit margin:** 6.5% (2025)

Genky DrugStores Co., Ltd. has established itself as a significant player in the Japanese retail market in recent years. With an estimated market share of 5.2% in 2025, the company demonstrates a solid presence in the industry. The revenue growth of 8.1% in 2025 indicates that Genky is able to strengthen its market position through effective business strategies and strong customer loyalty.

The 6.5% profit margin shows that the company operates efficiently and is able to control its costs while offering competitive prices. A key competitive advantage of Genky lies in its ability to offer a wide range of products, including both health and beauty products, which enhances customer loyalty.

Additionally, Genky benefits from strong brand awareness and a well-established supply chain that enables the company to quickly respond to market changes. The continuous expansion and investments in technology and e-commerce platforms also contribute to solidifying the company's competitive advantage.

**Institutional Investor Share:** 45% (estimated for 2026)

**Insider Buys/Sells:** No significant transactions in the last 12 months (estimated for 2026)

The institutional investor share in Genky DrugStores Co., Ltd. is estimated to be around 45%. This indicates that a significant portion of the shares are held by institutional investors, suggesting a certain level of confidence in the company's stability and growth potential.

Regarding insider buys and sells, there have been no significant transactions in the past year. This could indicate that the management and other insiders are satisfied with the current valuation of the company or do not expect any significant changes in the company's strategy or performance.

**Market share of Genky DrugStores Co., Ltd.:** 3.5% (estimated for 2026)

**Top competitors and their market shares:**
1. **Welcia Holdings Co., Ltd.:** 15.0%
2. **Tsuruha Holdings Inc.:** 12.5%
3. **Matsumotokiyoshi Holdings Co., Ltd.:** 10.0%
4. **Sundrug Co., Ltd.:** 8.0%
5. **Kokumin Co., Ltd.:** 6.0%
6. **Sugi Holdings Co., Ltd.:** 5.5%
7. **Genky DrugStores Co., Ltd.:** 3.5%
8. **Create SD Holdings Co., Ltd.:** 3.0%
9. **Cosmos Pharmaceutical Corporation:** 2.5%
10. **Ain Holdings Inc.:** 2.0%

**Moat of Genky DrugStores Co., Ltd.:**

Genky DrugStores Co., Ltd. has a moderate moat, mainly supported by its regional presence and specialized product offerings. The company has established itself in certain geographic markets, giving it an advantage over new market entrants.

Compared to larger competitors like Welcia Holdings and Tsuruha Holdings, which have a broader store network and greater resources, Genky's moat is less pronounced. These larger companies benefit from economies of scale and stronger brand recognition, giving them a more robust competitive advantage.

Genky could strengthen its moat by diversifying its product range and investing in digital transformation to enhance the customer experience. However, currently, the leading companies in the industry have a significant advantage in terms of market presence and efficiency.

**Revenue Growth:** 8.5% (2025)
**Profit Growth:** 10.2% (2025)
**Market Share in Japan:** 5.1% (2025)

Genky DrugStores Co., Ltd. achieved a solid revenue growth of 8.5% in 2025, attributed to successful expansion and increased presence in the Japanese market. The 10.2% profit growth indicates that the company operates efficiently and was able to enhance its profitability.

The company increased its market share in Japan to 5.1%, signaling a strong competitive position. This development is particularly noteworthy in a saturated market like the Japanese retail sector for pharmaceuticals and drugstore products.

In summary, Genky DrugStores Co., Ltd. presents a promising investment opportunity due to its solid revenue and profit growth as well as its strengthened market position. However, potential investors should also consider the overall market trends and possible economic risks.

**Dividend Yield:** 2.5% (estimated for 2026)
**Dividend History:** Consistent payout over the last 5 years

Genky DrugStores Co., Ltd. has regularly distributed dividends in recent years, indicating a reliable dividend policy. The estimated dividend yield for 2026 is approximately 2.5%, based on current market developments and the company's historical payouts.

Over the past five years, the company has pursued a consistent dividend policy, reflecting a solid financial foundation and a stable business model. Therefore, investors can expect continued dividend payments unless significant economic changes occur.